View Older Stories View More Recent Stories

Apr 7, 2026 06:02AM Oppenheimer on TransMedics Group (TMDX): 'Concerns on Jet Fuel Costs Misplaced'
Mar 16, 2026 09:37AM TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX): new label to be a 'preview of soon-to-be-published data'
Mar 9, 2026 07:57AM TransMedics Group (TMDX) PT Raised to $130 at Stifel: Remains 'Least Confident Hold'
Mar 9, 2026 07:57AM TransMedics Group (TMDX) PT Raised to $130 at Stifel: Remains Least Confident Hold'
Feb 27, 2026 07:01AM TransMedics clarifies tax valuation allowance impact on Q4 results
Feb 25, 2026 07:11AM TransMedics Group (TMDX) PT Raised to $174 at Needham
Feb 24, 2026 04:11PM TransMedics Group (TMDX) Tops Q4 EPS by $2.23, provides guidance
Feb 9, 2026 08:02AM TransMedics gets FDA approval for heart transplant trial
Feb 4, 2026 04:21PM TransMedics Group appoints Giovanni Cecere as chief commercial officer
Jan 21, 2026 03:41PM TransMedics stock falls after Bridge to Life wins FDA clearance for liver device
Jan 6, 2026 07:48AM TransMedics Group (TMDX) Reiterated at Hold by Stifel: Comp Headwinds Ahead
Jan 2, 2026 12:27AM Piper Sandler Reiterates Overweight Rating on TransMedics Group (TMDX)
Dec 22, 2025 07:02AM Piper Sandler on TransMedics Group (TMDX): 'NG Heart Trial Could Deliver Meaningful Upside'
Dec 8, 2025 06:26AM TransMedics Group (TMDX) PT Raised to $166 at Needham
Oct 30, 2025 06:34AM TransMedics Group (TMDX) PT Raised to $147 at Canaccord Genuity
Oct 30, 2025 04:50AM Needham Reiterates Buy Rating on TransMedics Group (TMDX)
Oct 29, 2025 04:13PM TransMedics Group (TMDX) Tops Q3 EPS by 30c, provides guidance
Oct 23, 2025 05:49AM Needham Upgrades TransMedics Group (TMDX) to Buy
Oct 14, 2025 07:13AM Stifel Reiterates Hold Rating on TransMedics Group (TMDX); Notes Share, End Market Weakness
Oct 13, 2025 02:12AM Jefferies Starts TransMedics Group (TMDX) at Buy
Oct 7, 2025 06:13AM Evercore Adds Names to TAP Lists
Sep 16, 2025 06:13AM Evercore ISI Starts TransMedics Group (TMDX) at Outperform
Sep 3, 2025 04:07PM Stifel Starts TransMedics Group (TMDX) at Hold
Aug 29, 2025 08:09AM TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)
Aug 4, 2025 08:01AM TransMedics gets FDA approval to start heart preservation trial
Jul 30, 2025 04:16PM TransMedics Group (TMDX) Tops Q2 EPS by 47c ; Offers Guidance
Jul 15, 2025 06:19AM TransMedics Group (TMDX) PT Raised to $142 at Canaccord Genuity
Jun 24, 2025 09:40AM TD Cowen's Best Smidcap Ideas 2025
Jun 17, 2025 06:03AM TransMedics Group (TMDX) PT Raised to $150 at Oppenheimer
Jun 4, 2025 08:30AM TransMedics Group (TMDX) PT Raised to $145 at Piper Sandler
May 9, 2025 06:02AM TransMedics Group (TMDX) PT Raised to $130 at Oppenheimer
May 8, 2025 04:25PM TransMedics Group (TMDX) Tops Q1 EPS by 44c ; Offers Guidance
May 1, 2025 04:50PM Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm
Apr 28, 2025 01:29PM Canaccord Genuity Reiterates Buy Rating on TransMedics Group (TMDX)
Apr 15, 2025 12:07PM Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against TransMedics Group, Inc. (TMDX)
Apr 14, 2025 12:32PM TMDX DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm -
Apr 14, 2025 12:04PM Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against TransMedics Group, Inc. (TMDX)
Apr 14, 2025 09:37AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group
Apr 14, 2025 08:07AM TMDX STOCK UPDATE: TransMedics Group Investors are Reminded to Contact BFA Law before the Expiration of Tomorrow's April 15 Class Action Deadline
Apr 13, 2025 04:00PM TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Apr 13, 2025 12:03PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against TransMedics Group, Inc. (TMDX)
Apr 13, 2025 09:09AM TMDX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed
Apr 12, 2025 12:01PM Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against TransMedics Group, Inc. (TMDX)
Apr 11, 2025 03:18PM TMDX STOCK ALERT: BFA Law Alerts TransMedics Group Investors of the Imminent April 15 Class Action Deadline
Apr 11, 2025 01:50PM TMDX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages TransMedics Group, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important April 15 Deadline in Securities Class
Apr 11, 2025 12:05PM Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Securities Class Action Against TransMedics Group, Inc. (TMDX)
Apr 10, 2025 12:00PM Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action That Has Been Filed Against TransMedics Group, Inc. (TMDX)
Apr 10, 2025 09:33AM TUESDAY INVESTOR DEADLINE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TMDX
Apr 10, 2025 07:46AM TMDX CLASS REMINDER: TransMedics Group Investors are Reminded to Contact BFA Law about the Pending Class Action by the April 15 Court Deadline
Apr 9, 2025 07:30PM TMDX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm
View More Recent Stories View Older Stories